Abstract
Objectives
This study investigated to identify the clinical significance of allodynia compared with other sensory hypersensitivities (SH) in migraine patients.
Methods
New patients with migraine were recruited from a headache clinic, and we collected data regarding their clinical characteristics and identified SH including photophobia, phonophobia, osmophobia, and allodynia. The patients completed the 12-item Allodynia Symptom Checklist, Migraine Disability Assessment Scale (MIDAS), Headache Impact Test-6 (HIT-6), Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder-7 (GAD-7), Insomnia Severity Index (ISI), Fatigue Severity Scale (FSS), and Migraine-Specific Quality of Life Questionnaire Version 2.1. We divided the patients into three groups: SH with allodynia (group 1), SH without allodynia (group 2), and no SH (group 3). Clinical characteristics, psychosomatic features, and quality of life (QOL) were compared among these groups.
Results
A total of 312 migraine patients participated in the study. Among them, 58 (18.6%), 202 (64.7%), and 52 (16.7%) were allocated to groups 1, 2, and 3, respectively. Chronic migraine, family history of migraine, medication overuse headache, earlier age at onset, longer disease duration, higher headache intensity, and aggravation with physical activity were more prevalent in group 1 than in groups 2 or 3. Scores of the MIDAS, HIT-6, PHQ-9, GAD-7, ISI, and FSS were the highest in group 1, followed by groups 2 and group 3. The lowest QOL was noted in group 1, followed by groups 2 and group 3.
Conclusions
This study revealed that SH in migraine, particularly combined with allodynia, may result in poor clinical outcomes.
Similar content being viewed by others
References
Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001) Prevalence and burden of migraine in the United States: data from the American migraine study II. Headache 41(7):646–657
Minen MT, Begasse De Dhaem O, Kroon Van Diest A, Powers S, Schwedt TJ, Lipton R, Silbersweig D (2016) Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry 87(7):741–749
Seo JG, Park SP (2018) Significance of fatigue in patients with migraine. J Clin Neurosci 50:69–73
Kim SY, Park SP (2014) The role of headache chronicity among predictors contributing to quality of life in patients with migraine: a hospital-based study. J Headache Pain 15(1):68
Park JW, Chu MK, Kim JM, Park SG, Cho SJ (2016) Analysis of trigger factors in episodic migraineurs using a smartphone headache diary applications. PLoS One 11(2):e0149577
Kao CH, Wang SJ, Tsai CF, Chen SP, Wang YF, Fuh JL (2014) Psychiatric comorbidities in allodynic migraineurs. Cephalalgia 34(3):211–218
Demarquay G, Mauguière F (2016) Central nervous system underpinnings of sensory hypersensitivity in migraine: insights from neuroimaging and electrophysiological studies. Headache 56(9):1418–1438
Lipton RB, Bigal ME, Ashina S, Burstein R, Silberstein S, Reed ML, Serrano D, Stewart WF, American Migraine Prevalence Prevention Advisory Group (2008) Cutaneous allodynia in the migraine population. Ann Neurol 63(2):148–158
Louter MA, Bosker JE, van Oosterhout WP, van Zwet EW, Zitman FG, Ferrari MD, Terwindt GM (2013) Cutaneous allodynia as a predictor of migraine chronification. Brain 136(Pt 11):3489–3496
Kim SY, Park SP (2016) Cutaneous allodynia and its risk factors in Korean patients with migraine: a survey of two tertiary care hospitals. J Oral Facial Pain Headache 30(4):323–329
Baykan B, Ekizoglu E, Karli N, Kocasoy-Orhan E, Zarifoglu M, Saip S, Siva A, Ertas M (2016) Characterization of migraineurs having allodynia: results of a large population-based study. Clin J Pain 32(7):631–635
Lovati C, D'Amico D, Bertora P, Raimondi E, Rosa S, Zardoni M, Bussone G, Mariani C (2010) Correlation between presence of allodynia and sleep quality in migraineurs. Neurol Sci 31(Suppl 1):S155–S158
Headache Classification Committee of the International Headache Society (IHS) (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33(9):629–808
Chu MK, Im HJ, Ju YS, Yu KH, Ma HI, Kim YJ, Kim J, Lee BC (2009) Validity and reliability assessment of Korean Headache Impact Test-6 (HIT-6). J Korean Neurol Assoc 27(1):1–6
Seo JG, Park SP (2015) Validation of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with migraine. J Headache Pain 16:65
Seo JG, Park SP (2015) Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine. J Headache Pain 16:97
Lee J, Shin C, Ko YH, Lim J, Joe SH, Kim S, Jung IK, Han C (2012) The reliability and validity studies of the Korean version of the Perceived Stress Scale. Korean J Psychosom Med 20(2):127–134
Cho YW, Lee JH, Son HK, Lee SH, Shin C, Johns MW (2011) The reliability and validity of the Korean version of the Epworth sleepiness scale. Sleep Breath 15(3):377–384
Cho YW, Song ML, Morin CM (2014) Validation of a Korean version of the insomnia severity index. J Clin Neurol 10(3):210–215
Chung KI, Song CH (2001) Clinical usefulness of fatigue severity scale for patients with fatigue, and anxiety or depression. Korean J Psychosom Med 9(2):164–173
Seo JG, Park SP (2017) Validation of the Korean Migraine-Specific Quality of Life Questionnaire version 2.1 in episodic and chronic migraine. J Oral Facial Pain Headache 31(3):251–256
Bayliss M, Batenhorst A (2002) The HIT-6™ a user’s guide. Quality Metric Incorporated, Lincoln
Pfizer. Patient Health Questionnaire (PHQ) screeners. http://www.phqscreeners.com/. Accessed Sep 2013
Pfizer. Patient Health Questionnaire (PHQ) screeners. http://www.phqscreeners.com/. Accessed Nov 2012
Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH (2000) An association between migraine and cutaneous allodynia. Ann Neurol 47(5):614–624
Mathew NT, Kailasam J, Seifert T (2004) Clinical recognition of allodynia in migraine. Neurology 63(5):848–852
Benatto MT, Florencio LL, Carvalho GF, Dach F, Bigal ME, Chaves TC, Bevilaqua-Grossi D (2017) Cutaneous allodynia is more frequent in chronic migraine, and its presence and severity seems to be more associated with the duration of the disease. Arq Neuropsiquiatr 75(3):153–159
Lipton RB, Munjal S, Buse DC, Bennett A, Fanning KM, Burstein R, Reed ML (2017) Allodynia is associated with initial and sustained response to acute migraine treatment: results from the American Migraine Prevalence and Prevention Study. Headache 57(7):026–1040
Antonaci F, Nappi G, Galli F, Manzoni GC, Calabresi P, Costa A (2011) Migraine and psychiatric comorbidity: a review of clinical findings. J Headache Pain 12(2):1–11
Mendonça MD, Caetano A, Viana-Baptista M, CHLO Headache Study Group (2016) Association of depressive symptoms with allodynia in patients with migraine: aA cross-sectional study. Cephalalgia 36(11):1077–1081
Tietjen GE, Brandes JL, Peterlin BL, Eloff A, Dafer RM, Stein MR, Drexler E, Martin VT, Hutchinson S, Aurora SK, Recober A, Herial NA, Utley C, White L, Khuder SA (2009) Allodynia in migraine: association with comorbid pain conditions. Headache 49(9):1333–1344
Acknowledgements
The authors thank Ju-Hui Lee, a neuropsychologist, for her help with the completion of self-report questionnaires.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Seo, JG., Park, SP. Clinical significance of sensory hypersensitivities in migraine patients: does allodynia have a priority on it?. Neurol Sci 40, 393–398 (2019). https://doi.org/10.1007/s10072-018-3661-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-018-3661-2